Placemark Investments’s United Therapeutics UTHR Stock Holding History

Placemark Investments’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$408K	Sell	3,144 -2,038	-39%	-$263K	0.01%	1273
2014 Q3	$667K	Sell	5,182 -2,541	-33%	-$262K	0.01%	1052
2014 Q2	$683K	Sell	7,723 -5,032	-39%	-$484K	0.01%	1042
2014 Q1	$1.2M	Sell	12,755 -1,177	-8%	-$120K	0.02%	739
2013 Q4	$1.57M	Buy	13,932 +1,644	+13%	+$148K	0.03%	658
2013 Q3	$972K	Buy	12,288 +597	+5%	+$43.6K	0.02%	818
2013 Q2	$769K	Buy	+11,691	New	+$753K	0.02%	858

Other funds holding UTHR

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Placemark Investments's UTHR Position: Q4 2014 in Review

Placemark Investments reduced its United Therapeutics (UTHR) stake by 39% in Q4 2014, selling an estimated $263K and leaving 3,144 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #1273.

Placemark Investments first reported a position in UTHR in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.57M in Q4 2013. 334 funds tracked by Wall St. Rank hold UTHR as of Q4 2014.

Placemark Investments held 3,144 shares of United Therapeutics worth $408K as of Q4 2014.
Placemark Investments sold 2,038 United Therapeutics shares in Q4 2014, an estimated $263K.
United Therapeutics made up 0.01% of Placemark Investments's portfolio in Q4 2014, its #1273 holding.
Placemark Investments first reported a position in United Therapeutics in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's United Therapeutics position peaked at $1.57M in Q4 2013.
334 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.